Show simple item record

dc.contributor.authorAhn, JS
dc.contributor.authorLin, J
dc.contributor.authorOgawa, S
dc.contributor.authorYuan, C
dc.contributor.authorO'Brien, T
dc.contributor.authorLe, BHC
dc.contributor.authorBothwell, AM
dc.contributor.authorMoon, H
dc.contributor.authorHadjiat, Y
dc.contributor.authorGanapathi, A
dc.date.accessioned2020-12-21T02:14:37Z
dc.date.available2020-12-21T02:14:37Z
dc.date.issued2017-01-01
dc.identifierpii: jpr-10-1963
dc.identifier.citationAhn, J. S., Lin, J., Ogawa, S., Yuan, C., O'Brien, T., Le, B. H. C., Bothwell, A. M., Moon, H., Hadjiat, Y. & Ganapathi, A. (2017). Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review. JOURNAL OF PAIN RESEARCH, 10, pp.1963-1972. https://doi.org/10.2147/JPR.S140320.
dc.identifier.issn1178-7090
dc.identifier.urihttp://hdl.handle.net/11343/256842
dc.description.abstractTreatment of cancer pain is generally based on the three-step World Health Organization (WHO) pain relief ladder, which utilizes a sequential approach with drugs of increasing potency. Goals of pain management include optimization of analgesia, optimization of activities of daily living, minimization of adverse effects, and avoidance of aberrant drug taking. In addition, it is recommended that analgesic regimens are individualized and simplified to help ensure patient compliance and should provide the least invasive, easiest, and safest route of opioid administration to ensure adequate analgesia. Buprenorphine and fentanyl are two opioids available for the relief of moderate-to-severe cancer pain. Available clinical data regarding the transdermal (TD) formulations of these opioids and the extent to which they fulfill the recommendations mentioned earlier are systematically reviewed, with the aim of providing additional information for oncologists and pain specialists regarding their comparative use. Due to lack of studies directly comparing TD buprenorphine with TD fentanyl, data comparing these with other step-3 opioids are also evaluated in a network fashion.
dc.languageEnglish
dc.publisherDOVE MEDICAL PRESS LTD
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0
dc.titleTransdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review
dc.typeJournal Article
dc.identifier.doi10.2147/JPR.S140320
melbourne.affiliation.departmentMedicine (RMH)
melbourne.affiliation.facultyMedicine, Dentistry & Health Sciences
melbourne.source.titleJournal of Pain Research
melbourne.source.volume10
melbourne.source.pages1963-1972
dc.rights.licenseCC BY-NC
melbourne.elementsid1233803
melbourne.contributor.authorLe, Brian
dc.identifier.eissn1178-7090
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record